Health care startups in Germany
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Tubulis | Munich | Series C | $400.6M | 2025-10-15 |
| Exciva | Heidelberg | Series B | $59.4M | 2026-01-20 |
| Seamless Therapeutics | Dresden | Seed | $12.6M | 2024-04-23 |
| NVision Quantum Technologies | Ulm | Series B | $38.0M | 2026-05-13 |
| DISCO Pharmaceuticals | Cologne | Seed | $42.3M | 2025-12-11 |
| Aware | Berlin | Seed | $15.0M | 2022-06-27 |
| Cellbox Solutions | Cologne | Series A | $1.7M | 2026-10-20 |
| Mindpeak | Hamburg | Series A | $15.3M | 2024-09-30 |
8 rows of the CSV in 5 of its 18 columns.
- The 659 health care startups in Germany have raised $4.9B in total.
- 55 of them closed their most recent round in the last 12 months, $468.4M combined.
- The largest of those rounds is Exciva's $59.4M Series B, dated January 2026.
- The most recent is SRTD Biotech's $35.2M seed round on 9 November 2026.
- HTGF (High-Tech Gruenderfonds) is an investor in 66 of them, more than any other fund.
- Software is the most common other sector, with 199 companies (30%).
- 41% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 1 to 10 employees (45% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 659| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Cellbox Solutions | Cellbox Solutions provides logistics solutions for the global biomedical industry. | Biotech | Cologne | Series A | $1.7M | 2026-10-20 | $15.3M | European Innovation Council, Fraunhofer Venture, CK Venture Capital | 11 to 50 | 2017 |
| Allogenetics | Allogenetics addresses organ rejection following transplantation. | Health care | Hanover | Seed | $4.4M | 2026-09-09 | $8.2M | NBank Capital, Carma Fund | 1 to 10 | 2022 |
| Xena | Xena uses artificial intelligence to assist gynecological surgeons during precision surgical procedures. | Artificial intelligence | Mannheim | Pre-seed | $327K | 2026-05-29 | $545K | Techstars | 1 to 10 | 2023 |
| NVision Quantum Technologies | NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. | Biotech | Ulm | Series B | $38.0M | 2026-05-13 | $155.2M | Entrée Capital, European Commission, Playground Global +2 | 101 to 250 | 2015 |
| Tacalyx | Tacalyx develops cancer therapies that target tumor-associated carbohydrate antigens. | Biotech | Berlin | Seed | $12.9M | 2026-04-29 | $28.0M | HTGF (High-Tech Gruenderfonds), coparion, Kurma Partners +2 | 1 to 10 | 2019 |
| mbiomics | mbiomics is a biotechnology company. | Biotech | Munich | Series A | $12.0M | 2026-04-28 | $26.1M | HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital | 11 to 50 | 2020 |
| dehaze | Dehaze brings medical AI models into clinical practice to provide healthcare services. | Artificial intelligence | Munich | Seed | $3.7M | 2026-04-28 | $3.8M | Techstars | 1 to 10 | 2023 |
| Cellbricks Therapeutics | Cellbricks Therapeutics is a biotech company developing methods for replacing tissue and organs. | Biotech | Berlin | Seed | $8.1M | 2026-03-25 | $11.6M | b.value AG, Brooks Hill Partners | 11 to 50 | 2016 |
| RAYDIAX | RAYDIAX manufactures therapy-assist CT systems that enable minimally invasive interventions. | Hardware | Magdeburg | Series A | $5.9M | 2026-03-01 | $12.5M | HTGF (High-Tech Gruenderfonds), bmp Ventures, Federal Ministry for Economic Cooperation and Development | 11 to 50 | 2022 |
| Custom Surgical | Custom Surgical builds AI-powered imaging data management and digitization tools for eyecare. | Health care | Munich | Seed | $4.1M | 2026-02-19 | $4.7M | Luminate | 11 to 50 | 2019 |
| Altavo | Altavo develops medical devices as a startup. | Health care | Dresden | Series A | $3.5M | 2026-01-22 | $8.9M | HTGF (High-Tech Gruenderfonds), TGFS - Technologiegründerfonds Sachsen, bm-t beteiligungsmanagement thuringen +2 | 11 to 50 | 2021 |
| Exciva | Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. | Biotech | Heidelberg | Series B | $59.4M | 2026-01-20 | $69.8M | Andera Partners, LBBW VC, Cure8 Ventures | 1 to 10 | 2015 |
| DISCO Pharmaceuticals | DISCO Pharmaceuticals performs large-scale surfaceome mapping of cancer cells to find drug targets. | Health care | Cologne | Seed | $42.3M | 2025-12-11 | $64.0M | Sofinnova Partners, M Ventures, AbbVie +1 | 11 to 50 | 2022 |
| Mirantus Health | Mirantus Health is building a distributed healthcare provider to improve access to care for underserved patients. | Health care | Berlin | Seed | $6.3M | 2025-11-20 | $6.3M | Revent, Springboard Health Angels | 11 to 50 | 2022 |
| 4TEEN4 Pharmaceuticals | 4TEEN4 Pharmaceuticals develops therapies and biomarkers for diagnosing, predicting, and treating circulatory shock. | Biotech | Hennigsdorf | Series C | $36.1M | 2025-11-13 | $95.9M | Wellington Partners, Brandenburg Kapital, HBM Healthcare Investments +1 | 11 to 50 | 2013 |
| Tubulis | Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications. | Biotech | Munich | Series C | $400.6M | 2025-10-15 | $616.9M | HTGF (High-Tech Gruenderfonds), Bayern Kapital, Seventure Partners +1 | 51 to 100 | 2012 |
| HEY HOLY | HEY HOLY sells breed-specific dog food through subscriptions. | Health care | Mannheim | Series A | $6.6M | 2025-07-16 | $9.8M | Slingshot Ventures | 11 to 50 | 2022 |
| Elixion Medical | Elixion Medical applies AI and IoT to hospital care. | Artificial intelligence | Düsseldorf | Seed | $2.2M | 2025-05-13 | $2.6M | NRW.BANK | 1 to 10 | 2021 |
| Clinomic | Clinomic is a medical AI company focused on critical care. | Artificial intelligence | Aachen | Series B | $25.3M | 2025-04-08 | $54.6M | German Federal Ministry of Research, Technology and Space | 51 to 100 | 2019 |
| UniteLabs | UniteLabs provides an automation operating system for laboratories. | Biotech | Munich | Pre-seed | $3.1M | 2025-04-03 | $3.1M | Venture Kick | 11 to 50 | 2022 |
| Vivalyx | Vivalyx works to save organ failure patients by boosting the vitality and number of donor organs. | Health care | Aachen | Seed | $6.3M | 2025-02-19 | $16.3M | VentureOut, Leblon Capital, TechVision Fund +1 | 1 to 10 | 2022 |
| Aignostics | Aignostics is a company that provides AI-powered pathology diagnostics for drug development and clinical research. | Artificial intelligence | Berlin | Series B | $34.0M | 2024-10-29 | $54.8M | HTGF (High-Tech Gruenderfonds), IBB Ventures, Wellington Partners +1 | 101 to 250 | 2018 |
| Mindpeak | Mindpeak develops AI-based diagnostic software that detects, quantifies, and classifies cancer. | Artificial intelligence | Hamburg | Series A | $15.3M | 2024-09-30 | European Innovation Council, EIC Accelerator, Nina Capital +2 | 11 to 50 | 2018 | |
| Aurora Life Science | Aurora Life Science develops AI, mobile app, and digital health solutions. | Biotech | Darmstadt | Pre-seed | $903K | 2024-08-14 | BM H Beteiligungs-Managementgesellschaft Hessen | 1 to 10 | 2019 | |
| PL BioScience | PL BioScience delivers 2D and 3D cell culture solutions based on human Platelet Lysate. | Biotech | Aachen | Series A | $8.5M | 2024-08-08 | $13.0M | TechVision Fund, better ventures, Brightlands Venture Partners +1 | 11 to 50 | 2015 |
| deepc | deepc provides an AI operating system for radiology. | Artificial intelligence | Munich | Series A | $13.0M | 2024-07-25 | $26.0M | VentureOut, Sofinnova Partners, Bertelsmann Investments +2 | 11 to 50 | 2019 |
| CatalYm | CatalYm develops immunotherapies to treat cancer. | Biotech | Planegg | Series D | $150.0M | 2024-07-16 | $260.9M | Bayern Kapital, Forbion Capital Partners, Novartis Venture Fund +1 | 11 to 50 | 2016 |
| Heidelberg Epignostix | Heidelberg Epignostix categorizes tumors using DNA methylation-based analysis. | Health care | Heidelberg | Seed | $4.6M | 2024-07-02 | $4.6M | HTGF (High-Tech Gruenderfonds), LBBW VC, Start-up BW Innovation Fonds +1 | 1 to 10 | 2022 |
| CUREosity | CUREosity provides VR-based therapy solutions on a SaaS model. | Hardware | Düsseldorf | Seed | $4.1M | 2024-06-24 | $9.4M | TechVision Fund, Nomainvest | 51 to 100 | 2018 |
| apoQlar | apoQlar uses mixed reality to support surgical care and medical education. | Health care | Hamburg | Series A | $10.8M | 2024-05-05 | $10.8M | IFB Innovationsstarter, YZR Capital | 51 to 100 | 2017 |
Table 1. Health care startups in Germany: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 659.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Exciva | Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. | Biotech | Heidelberg | Series B | $59.4M | 2026-01-20 | $69.8M | Andera Partners, LBBW VC, Cure8 Ventures | 1 to 10 | 2015 |
| 2 | DISCO Pharmaceuticals | DISCO Pharmaceuticals performs large-scale surfaceome mapping of cancer cells to find drug targets. | Health care | Cologne | Seed | $42.3M | 2025-12-11 | $64.0M | Sofinnova Partners, M Ventures, AbbVie +1 | 11 to 50 | 2022 |
| 3 | NVision Quantum Technologies | NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. | Biotech | Ulm | Series B | $38.0M | 2026-05-13 | $155.2M | Entrée Capital, European Commission, Playground Global +2 | 101 to 250 | 2015 |
| 4 | Tacalyx | Tacalyx develops cancer therapies that target tumor-associated carbohydrate antigens. | Biotech | Berlin | Seed | $12.9M | 2026-04-29 | $28.0M | HTGF (High-Tech Gruenderfonds), coparion, Kurma Partners +2 | 1 to 10 | 2019 |
| 5 | mbiomics | mbiomics is a biotechnology company. | Biotech | Munich | Series A | $12.0M | 2026-04-28 | $26.1M | HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital | 11 to 50 | 2020 |
| 6 | Cellbricks Therapeutics | Cellbricks Therapeutics is a biotech company developing methods for replacing tissue and organs. | Biotech | Berlin | Seed | $8.1M | 2026-03-25 | $11.6M | b.value AG, Brooks Hill Partners | 11 to 50 | 2016 |
| 7 | Mirantus Health | Mirantus Health is building a distributed healthcare provider to improve access to care for underserved patients. | Health care | Berlin | Seed | $6.3M | 2025-11-20 | $6.3M | Revent, Springboard Health Angels | 11 to 50 | 2022 |
| 8 | RAYDIAX | RAYDIAX manufactures therapy-assist CT systems that enable minimally invasive interventions. | Hardware | Magdeburg | Series A | $5.9M | 2026-03-01 | $12.5M | HTGF (High-Tech Gruenderfonds), bmp Ventures, Federal Ministry for Economic Cooperation and Development | 11 to 50 | 2022 |
| 9 | Allogenetics | Allogenetics addresses organ rejection following transplantation. | Health care | Hanover | Seed | $4.4M | 2026-09-09 | $8.2M | NBank Capital, Carma Fund | 1 to 10 | 2022 |
| 10 | Custom Surgical | Custom Surgical builds AI-powered imaging data management and digitization tools for eyecare. | Health care | Munich | Seed | $4.1M | 2026-02-19 | $4.7M | Luminate | 11 to 50 | 2019 |
Table 2. Health care startups in Germany: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 66 | 10% | 5 | CereGate, Tacalyx, mbiomics |
| 2 | Bayern Kapital | Venture capital firm | Landshut, Germany | 19 | 3% | 1 | mbiomics |
| 3 | KfW | Government investment office | Frankfurt, Germany | 19 | 3% | ||
| 4 | IBB Ventures | Venture capital firm | Berlin, Germany | 12 | 2% | 1 | Ascléa |
| 5 | Wellington Partners | Venture capital firm | Munich, Germany | 7 | 1% | ||
| 6 | Andera Partners | Private equity firm | Paris, France | 6 | 1% | 1 | Exciva |
| 7 | German Federal Ministry of Research, Technology and Space | Government investment office | Bonn, Germany | 6 | 1% | 1 | NVision Quantum Technologies |
| 8 | Atlantic | Venture capital firm | Berlin, Germany | 6 | 1% | ||
| 9 | Fraunhofer Venture | Venture capital firm | Munich, Germany | 6 | 1% | 1 | Cellbox Solutions |
| 10 | seed + speed Ventures | Venture capital firm | Berlin, Germany | 6 | 1% | ||
| 11 | MIG Capital | Venture capital firm | Munich, Germany | 6 | 1% | 1 | mbiomics |
| 12 | APX | Venture capital firm | Berlin, Germany | 6 | 1% | ||
| 13 | bmp Ventures | Venture capital firm | Berlin, Germany | 6 | 1% | 1 | RAYDIAX |
| 14 | TechVision Fund | Venture capital firm | Aachen, Germany | 6 | 1% | ||
| 15 | LBBW VC | Corporate venture arm | Stuttgart, Germany | 5 | 1% | 1 | Exciva |
Table 3. Health care startups in Germany: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 199 | 30% | $803.7M |
| Biotech | 177 | 27% | $2.4B |
| Artificial intelligence | 77 | 12% | $467.5M |
| Commerce | 34 | 5% | $128.5M |
| Hardware | 33 | 5% | $31.8M |
| Fintech | 24 | 4% | $274.7M |
| Education | 11 | 2% | $18.8M |
| Energy | 4 | 1% | $35.1M |
| Cybersecurity | 2 | 0% |
Table 4. Health care startups in Germany by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in Germany by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Health care startups in Germany by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 2 | 4% | $35.2M |
| October 2026 | 4 | 7% | $2.2M |
| September 2026 | 5 | 9% | $41.6M |
| August 2026 | 2 | 4% | $7.2M |
| July 2026 | 3 | 5% | $4.6M |
| June 2026 | 5 | 9% | $62.8M |
| May 2026 | 5 | 9% | $44.2M |
| April 2026 | 7 | 13% | $56.0M |
| March 2026 | 4 | 7% | $24.4M |
| February 2026 | 5 | 9% | $43.8M |
| January 2026 | 7 | 13% | $69.3M |
| December 2025 | 4 | 7% | $68.1M |
| November 2025 | 2 | 4% | $9.1M |
Table 7. Health care startups in Germany: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 49 | 7% | $391.1M |
| 2025 | 63 | 10% | $719.3M |
| 2024 | 82 | 12% | $749.1M |
| 2023 | 74 | 11% | $264.0M |
| 2022 | 108 | 16% | $515.5M |
| 2021 | 53 | 8% | $474.8M |
Table 8. Health care startups in Germany by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 62 | 10% |
| 2020 to 2022 | 206 | 32% |
| 2015 to 2019 | 229 | 35% |
| 2010 to 2014 | 94 | 14% |
| Before 2010 | 58 | 9% |
Table 9. Health care startups in Germany by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 293 | 45% |
| 11 to 50 | 277 | 43% |
| 51 to 100 | 44 | 7% |
| 101 to 250 | 18 | 3% |
| 251 to 500 | 12 | 2% |
| 501 to 1,000 | 4 | 1% |
| 1,001 to 5,000 | 2 | 0% |
| 10,001 or more | 1 | 0% |
Table 10. Health care startups in Germany by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Germany. On 16 November 2026 that is 659 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 659 rows: 264 have no round amount, 0 no city and 271 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Germany are on the list?
- 659, in the file dated 16 November 2026. 55 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 659 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.